Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRAMETINIB DIMETHYLSULFOXIDE, with a corresponding US DMF Number 35525.
Remarkably, this DMF maintains an Active status since its submission on December 31, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2022, and payment made on January 06, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II